38,40,41 Persons with SMI-SUD more often are financially precarious and have inequitable access to GLP-1 RAs, which could increase the likelihood that they will seek out these agents via online pharmacies/compounding use
so, when a scan shows less muscle mass after weight loss with glp-1s, it might be showing muscle getting leaner, i.e., losing the fat that surrounds the muscle, and not the muscle itself
Its uncertain whether hair loss stems from rapid caloric deficit impacting hair follicles or a direct effect of the drugs themselves. Research indicates those on semaglutide-based drugs like Ozempic have a higher risk of hair loss, especially women, compared to other weight-loss treatments
Are overweight or have obesity, especially if they also have diabetes or other health risks (Trulicity and Mounjaro are not indicated for the treatment of overweight or obesity, however)